Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
the webinars (and there are plenty of them) are a good starter as well. CF does a good job of providing forward guidance, but not in an unreliable BF way.
Meant to say I disagree about the sale of non core assets making a difference to any takeover
I disagree. When was the last time you have seen a takeover based on multiples of the current share price?
We all know OO is due a rerate in due course with the pipeline of things to come. I think given its current size and management it is probably a lot more agile compared to other companies
Ex hvivo here with a 24p average. I had pretty much written off my shares here so nice to see them within touching distance. If you said to me earlier this year i would get my money back i would have sold all of mine straight away.
Am now in for the long haul. The luck of the Irish might be with CF but I am happy to see Orphan come up trumps (no pun intended)
The first time I heard of the vaccine offering only a year's immunity was C.F. 2 weeks ago on a webinar presentation.
Long term holder since hvivo days. Am i missing something or could hvivo run a challenge study on flu-v?
Assume open orphan would just increase its stake as part of the deal.
Was listening to radio 4 earlier. Seems the government will push FLU vaccines this year to 'protect the nhs'.
If covid vaccines can be fast tracked to stage 3 quickly then why is there not the same impetus to get it done for universal flu?
They did say conservative
Here is my tuppence worth.
Novacyt has the advantage as first to market. Genedrive coming online might impact pricing in the UK.
If the government strategy is to introduce a passporting system then the 'have I had it' will take off.
I'm unclear on the size of the market for tests. Its a question straight out of the dragons den handbook.
Using the UK and an approx population of 60m. Can someone provide an estimate on the expected number of sales till the end of the year and the rationale please.
OO is ticking along nicely. No erratic up movement followed by the usual retrace.
Today's RNS has seriously derisked this share ... with the board change. As a bonus we also have a new contract.
Do any ex hvivo shareholders know when we will receive our Orphan shares? I spoke to II and they told me there is some legal side that needs resolving but no date given